Exposure–response analysis of acalabrutinib and its active metabolite, ACP‐5862, in patients with B‐cell malignancies
暂无分享,去创建一个
J. Ware | H. Edlund | H. Tomkinson | Huan Liu | K. Vishwanathan | Shringi Sharma | P. Patel | Marshall S. Baek | Helen Wei | N. Buil-Bruna | M. de Kock | Zhongqing He | R. Raman | Marshall Baek